Wells Fargo’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $31K | Sell |
6,595
-10
| -0.2% | -$51 | ﹤0.01% | 5621 |
|
|
2025
Q4 | $28.1K | Buy |
6,605
+3,000
| +83% | +$11.4K | ﹤0.01% | 5699 |
|
|
2025
Q3 | $11.5K | Buy |
+3,605
| New | +$8.12K | ﹤0.01% | 5916 |
|
|
2024
Q2 | – | Sell |
-524
| Closed | -$1.14K | – | 7019 |
|
|
2024
Q1 | $1.14K | Buy |
524
+9
| +2% | +$17 | ﹤0.01% | 6120 |
|
|
2023
Q4 | $798 | Buy |
515
+28
| +6% | +$37 | ﹤0.01% | 6282 |
|
|
2023
Q3 | $628 | Buy |
487
+9
| +2% | +$14 | ﹤0.01% | 6315 |
|
|
2023
Q2 | $822 | Buy |
478
+21
| +5% | +$35 | ﹤0.01% | 6370 |
|
|
2023
Q1 | $690 | Buy |
457
+7
| +2% | +$16 | ﹤0.01% | 6478 |
|
|
2022
Q4 | $720 | Buy |
450
+12
| +3% | +$18 | ﹤0.01% | 6283 |
|
|
2022
Q3 | $1K | Buy |
438
+31
| +8% | +$48 | ﹤0.01% | 6309 |
|
|
2022
Q2 | $1K | Sell |
407
-84,824
| -100% | -$162K | ﹤0.01% | 6489 |
|
|
2022
Q1 | $228K | Sell |
85,231
-19,393
| -19% | -$74.5K | ﹤0.01% | 4904 |
|
|
2021
Q4 | $452K | Buy |
104,624
+14,055
| +16% | +$82.3K | ﹤0.01% | 4740 |
|
|
2021
Q3 | $460K | Buy |
90,569
+37,591
| +71% | +$201K | ﹤0.01% | 4710 |
|
|
2021
Q2 | $335K | Sell |
52,978
-91,777
| -63% | -$715K | ﹤0.01% | 4812 |
|
|
2021
Q1 | $1.12M | Buy |
144,755
+44,940
| +45% | +$356K | ﹤0.01% | 4163 |
|
|
2020
Q4 | $654K | Sell |
99,815
-7,496
| -7% | -$53.6K | ﹤0.01% | 4331 |
|
|
2020
Q3 | $714K | Buy |
107,311
+6,702
| +7% | +$49.7K | ﹤0.01% | 4101 |
|
|
2020
Q2 | $838K | Buy |
100,609
+73,726
| +274% | +$685K | ﹤0.01% | 3949 |
|
|
2020
Q1 | $206K | Buy |
26,883
+2,297
| +9% | +$16K | ﹤0.01% | 4665 |
|
|
2019
Q4 | $204K | Buy |
24,586
+22
| +0.1% | +$148 | ﹤0.01% | 4944 |
|
|
2019
Q3 | $181K | Buy |
24,564
+1,408
| +6% | +$13.9K | ﹤0.01% | 5012 |
|
|
2019
Q2 | $260K | Sell |
23,156
-56,880
| -71% | -$596K | ﹤0.01% | 4819 |
|
|
2019
Q1 | $861K | Sell |
80,036
-28,189
| -26% | -$417K | ﹤0.01% | 3990 |
|
|
2018
Q4 | $1.63M | Buy |
108,225
+13,240
| +14% | +$196K | ﹤0.01% | 3443 |
|
|
2018
Q3 | $1.76M | Buy |
94,985
+4,020
| +4% | +$91.6K | ﹤0.01% | 3519 |
|
|
2018
Q2 | $2.08M | Buy |
90,965
+31,364
| +53% | +$801K | ﹤0.01% | 3428 |
|
|
2018
Q1 | $1.7M | Sell |
59,601
-82,353
| -58% | -$2.35M | ﹤0.01% | 3499 |
|
|
2017
Q4 | $3M | Buy |
141,954
+81,215
| +134% | +$1.68M | ﹤0.01% | 3041 |
|
|
2017
Q3 | $1.1M | Buy |
60,739
+19,506
| +47% | +$304K | ﹤0.01% | 3770 |
|
|
2017
Q2 | $639K | Buy |
41,233
+18,809
| +84% | +$284K | ﹤0.01% | 4053 |
|
|
2017
Q1 | $387K | Buy |
22,424
+7,747
| +53% | +$102K | ﹤0.01% | 4416 |
|
|
2016
Q4 | $161K | Buy |
14,677
+6,869
| +88% | +$83.2K | ﹤0.01% | 4882 |
|
|
2016
Q3 | $122K | Buy |
7,808
+5,600
| +254% | +$67.8K | ﹤0.01% | 4794 |
|
|
2016
Q2 | $23K | Sell |
2,208
-155
| -7% | -$1.77K | ﹤0.01% | 5459 |
|
|
2016
Q1 | $31K | Buy |
2,363
+128
| +6% | +$1.78K | ﹤0.01% | 5388 |
|
|
2015
Q4 | $47K | Buy |
+2,235
| New | +$35.4K | ﹤0.01% | 5305 |
|
Other funds holding CTMX
KCM
PA
VA
VCM
